Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis

The Journal of Antimicrobial Chemotherapy
M E Rupp, K E Hamer

Abstract

Staphylococcus epidermidis is the preeminent cause of nosocomial bacteraemia and infection of prosthetic medical devices. Bacterial adherence to biomaterial is a crucial early event in the pathogenesis of these infections. Antibiotics affect bacterial adherence to eukaryotic cells, capsule formation and biofilm production. However, results from studies involving coagulase-negative staphylococci are equivocal. In this study, the in-vitro adherence of radiolabelled bacteria was assayed to determine the effect of sublethal concentrations of a number of antibiotics on the attachment of four strains of S. epidermidis, with well-characterized adherence profiles, to intravascular catheters. The effect of antibiotics on biofilm production by S. epidermidis was assayed using a quantitative spectrophotometric assay. Although there was some strain-to-strain variability, none of the tested antibiotics affected bacterial attachment. However, treatment with cefazolin or vancomycin resulted in a significant decrease in biofilm elaboration. These data suggest that bacterial attachment by S. epidermidis, the initiating event associated with prosthetic device infection, cannot be prevented by subtherapeutic levels of fluoroquinolone, glycopeptid...Continue Reading

Citations

May 29, 2004·International Journal of Antimicrobial Agents·Paul J PaganoJohn K Gibson
Jul 21, 2001·International Journal of Antimicrobial Agents·A A KadryA M Shibl
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Julie A WuJohn F Kokai-Kun
Nov 28, 2015·Sensors·Katarína MlynárikováVeronika Holá
Oct 16, 2004·Letters in Applied Microbiology·N CercaJ Azeredo
Mar 13, 2003·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Jürgen PinocyGerhard Ziemer
Jun 15, 2001·Phytotherapy Research : PTR·S Pérez GR M Pérez G
Jun 8, 2006·The Journal of Bone and Joint Surgery. American Volume·Mete MecikogluTanil Esemenli
Aug 12, 2010·The Journal of Nervous and Mental Disease·Kikuko CampbellHaiyi Xie
Aug 18, 2004·Journal of Medical Microbiology·A P FonsecaJ C Sousa
Nov 19, 2011·The International Journal of Artificial Organs·Jeffrey B Kaplan
Nov 3, 2017·Scientific Reports·Katarína RebrošováPetr Petráš

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.